Four teams from the Northeast Region of the HOPE Animal-Assisted Crisis Response organization were recently called to ...

SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating the safety ...

Shares of Rigel Pharmaceuticals (RIGL) have gained 24.6% over the past four weeks to close the last trading session at $21.65, but there could still be a solid upside left in the stock if short ...

Singapore-based Rigel Capital is set to announce the final close of its first early-stage fund, Rigel Star, at slightly over $40 million soon, pushing the total capital the firm has raised across its ...

In the press release titled “Rigel Provides Business Update and 2025 Outlook,” Rigel Pharmaceuticals shared some significant financial highlights. For the fourth quarter of 2024, the company ...

I pick out North America’s celestial highlights for the week ahead (which also apply to mid-northern latitudes in the northern hemisphere).

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...